Storia in 18 fonti

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

--AstraZeneca has held talks to combine with Bristol Myers Squibb, the Financial Times reports, citing unnamed sources.

Raccontata da

manager-magazin.de+6 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

endpoints.news1 g fa

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca & Bristol Myers Squibb in merger talks per Financial Times. AZ worth ~$265B, BMS ~$133B. Deal may involve stock & cash; talks may not lead to deal.

Leggi questa versione → originale

axios.com

Timeline cronologica

domenica 2 agosto 2026·handelsblatt.com
Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb
Es wäre eine der größten Fusionen in der Wirtschaftsgeschichte. Laut einem Medienbericht wurden entsprechende Gespräche geführt. Ob es zu einem Zusammenschluss kommt ist jedoch…
domenica 2 agosto 2026·valor.globo.com
AstraZeneca explora possível fusão com a Bristol Myers Squibb, diz jornal
União poderia criar gigante farmacêutica de US$ 400 bilhões em valor de mercado

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Confronto fonti

AstraZeneca, Bristol Myers are in talks about merger — report

Timeline cronologica

Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb

AstraZeneca explora possível fusão com a Bristol Myers Squibb, diz jornal

Pharma giants AstraZeneca and Bristol-Myers in reported merger talks

AstraZeneca said to have explored Bristol Myers merger | Fortune

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

UK's AstraZeneca eyeing $400b merger, report says

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

AstraZeneca se spaja s američkim divom. Posao vrijedi 350 milijardi eura

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

La potentielle fusion avec Bristol-Myers Squibb fait plonger AstraZeneca - Le Temps

Ft: AstraZeneca tratta con Bristol Myers Squibb fusione da 400 mld

AstraZeneca: Pharmakonzern prüft 400-Milliarden-Dollar-Fusion mit Bristol Myers

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

AstraZeneca et Bristol Myers Squibb en pourparlers pour une fusion potentielle de près de 400 milliards

Financial Times: 'AstraZeneca tratta con Bristol Myers Squibb per una maxi fusione da 400 miliardi' - Notizie - Ansa.it

AstraZeneca, BMS discuss $400B pharma mega-deal

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’